You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent renal cell cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)

Recruiting
  • Acute Myeloid Leukemia
  • Graft cell infusion
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 29, 2023

Weight, Body Trial in Chicago (Time restircted eating, Time restricted eating + prebiotic, Control)

Not yet recruiting
  • Weight, Body
  • Time restircted eating
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
Apr 21, 2023

Chronic Graft-versus-host-disease Trial in Worldwide (Axatilimab)

Recruiting
  • Chronic Graft-versus-host-disease
  • Birmingham, Alabama
  • +69 more
Feb 18, 2022

Colo-rectal Cancer Trial (biological, drug, procedure)

Not yet recruiting
  • Colo-rectal Cancer
  • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
  • +8 more
  • (no location specified)
Aug 28, 2023

Relapsed/Refractory Large B-cell Lymphoma Trial in United States (Cyclophosphamide, Fludarabine, Lenzilumab)

Terminated
  • Relapsed/Refractory Large B-cell Lymphoma
  • Palo Alto, California
  • +9 more
Aug 26, 2022

Targeting Inflammation for Endometrial Cancer Prevention

Recruiting
  • Endometrial Carcinoma
  • Biospecimen Collection
  • Questionnaire Administration
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 5, 2023

Cancer Trial in London (Self-acupuncture)

Not yet recruiting
  • Cancer
  • Self-acupuncture
  • London, United Kingdom
    UCH Macmillan Cancer Centre
Jun 28, 2023

Breast Cancer, Breast Fibroadenoma, Breast Hypoplasia Trial in Hangzhou (cfDNA sequencing)

Recruiting
  • Breast Cancer
  • +2 more
  • cfDNA sequencing
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital of Zhejiang University School of Medi
Aug 28, 2023

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoid Leukemia Trial in Beijing

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • chimeric antigen receptor T cell
  • Beijing, Beijing, China
    Beijing Boren Hospital
Aug 12, 2022

Palliative Oncology Setting? A Pragmatic Clinical Trial

Not yet recruiting
  • Cancer
    • London, Ontario, Canada
      London Regional Cancer Program, London Health Sciences Centre
    Dec 4, 2023

    Advanced or Metastatic NSCLC Trial in Shanghai (drug, device, combination product)

    Not yet recruiting
    • Advanced or Metastatic NSCLC
    • Shanghai, Shanghai, China
      Lan Mu
    Jun 29, 2021

    IgG Subclasses and on Immunity of Secondary Immunodeficiency

    Completed
    • Secondary Immune Deficiency
    • Chalon-sur-Saône, France
    • +5 more
    Feb 28, 2022

    Pancreatic Cancer Trial in Goyang-si

    Active, not recruiting
    • Pancreatic Cancer
      • Goyang-si, Gyeonggi-do, Korea, Republic of
        NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,
      Sep 27, 2022

      Nasopharyngeal Carcinoma Trial in Guangzhou (Camrelizumab, Apatinib)

      Not yet recruiting
      • Nasopharyngeal Carcinoma
      • Guangzhou, Guangdong, China
        Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
      Sep 7, 2020

      Renal Impairment Trial in Miami, Saint Paul (PF-06651600)

      Terminated
      Has Results
      • Renal Impairment
      • Miami, Florida
      • +2 more
      Apr 27, 2021

      CHOKAI vs STONE Score to Predict Presence of Ureteric Stones in

      Recruiting
      • Ureteric Stone
        • Abu Dhabi, United Arab Emirates
        • +2 more
        Feb 7, 2022

        Cardiorespiratory Fitness and Lung Function in Lung Cancer

        Not yet recruiting
        • Non Small Cell Lung Cancer
        • Multimodal prehabilitation
        • (no location specified)
        Dec 2, 2022

        Nonsmall Cell Lung Cancer, Performance Status Trial in Winston-Salem (Pembrolizumab, Carboplatin, Paclitaxel)

        Recruiting
        • Nonsmall Cell Lung Cancer
        • Performance Status
        • Winston-Salem, North Carolina
          Wake Forest Baptist Comprehensive Cancer Center
        Dec 19, 2022

        Lung Cancer Trial in Philadelphia (drug, procedure, radiation)

        Completed
        Has Results
        • Lung Cancer
        • Philadelphia, Pennsylvania
          Fox Chase Cancer Center - Philadelphia
        Jan 5, 2022

        Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Oklahoma City (Sipuleucel-T)

        Not yet recruiting
        • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
        • Sipuleucel-T
        • Oklahoma City, Oklahoma
          Stephenson's Cancer Center
        Mar 28, 2023

        Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, Anatomic Stage III Breast Cancer Trial in United States

        Not yet recruiting
        • Anatomic Stage I Breast Cancer
        • +3 more
        • Endocrine Therapy
        • +7 more
        • Atlanta, Georgia
        • +4 more
        Jun 15, 2023

        Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)

        Not yet recruiting
        • Hematological Malignancies
        • Allogeneic T cell progenitors, cultured ex-vivo
        • (no location specified)
        Mar 2, 2023

        Stomach Cancer;Clinical Control Trial Trial in Taizhou (Marital self disclosure)

        Recruiting
        • Stomach Cancer；Clinical Control Trial
        • Marital self disclosure
        • Taizhou, Jiangsu, China
          Jingjiang people's Hospital
        Oct 31, 2022

        Type 2 Diabetes Trial in Worldwide (Sotagliflozin (SAR439954), Placebo, Metformin)

        Completed
        Has Results
        • Type 2 Diabetes Mellitus
        • Sotagliflozin (SAR439954)
        • +2 more
        • Birmingham, Alabama
        • +92 more
        Apr 16, 2021

        The Registry Study of Takayasu Arteritis in East China

        Recruiting
        • Takayasu Arteritis
        • +4 more
        • Shanghai, Shanghai, China
          Department of Rheumatology in Zhongshan hospital, Fudan Universi
        Aug 7, 2021